The most common glycans are N-glycans that are linked to asparagine residues (Stanley, P., Taniguchi, N., et al. 2015) and O-Glycans that are linked to serine/threonine residues (Brockhausen, I. and Stanley, P. 2015) . They are commonly found on cell surface, and involved in cell-cell, cell-extracellular matrix, and cell-pathogen interactions, and therefore play important roles in cell growth, differentiation and migration, innate immunity, and pathogenesis (Tabak, L.A. 2010 , Taniguchi, N. and Kizuka, Y. 2015 , Varki, A. 2017 . When sialylated, they bind to numerous selectins expressed on mammalian cells (Crocker, P.R., Clark, E.A., et al. 1998 ) and function as binding targets for a large number of pathogenic organisms and their toxins (Schauer, R. 2009 , Varki, A. 2008 . They are also involved in cancer malignancy and inflammation, and therefore are potential targets for therapeutic and diagnostic intervention (Dube, D.H. and Bertozzi, C.R. 2005, Magalhaes, A., Duarte, H.O., et al. 2017) . For their important biological functions and therapeutic and diagnostic applications, specific imaging or detection of these glycans is especially valuable (Chen, X. and Varki, A. 2010, Cummings, R.D. and Pierce, J.M. 2014 ).
N-glycans and O-glycans can be sialylated by multiple sialyltransferases (Harduin-Lepers, A., Mollicone, R., et al. 2005) (Fig. 1A and 1B ). N-glycan sialylation typically occurs on Gal residues and is mediated by the N-glycan specific α -2,6-sialyltransferase 1 (ST6Gal1) (Weinstein, J., Lee, E.U., et al. 1987 ) and maybe α -2,3-sialyltransferase 4 (ST3Gal4) (Mereiter, S., Magalhaes, A., et al. 2016) . O-glycan synthesis is initiated with an O-GalNAc residue that can be elongated to Core-1 O-glycan (T antigen, Galβ1,3-GalNAc-O-S/T) (Ju, T. and Cummings, R.D. 2005 ) that can be further sialylated by the O-glycan specific α -2,3sialyltransferase 1 and 2 (ST3Gal1 and ST3Gal2) to generate sialyl-T antigen (sT antigen, Siaα2,3-Galβ1-3GalNAc-O-S/T) (Ju, T., Lanneau, G.S., et al. 2008, Kitagawa, H. and Paulson, J.C. 1994) . O-GalNAc residue can also be directly sialylated at C-6 by a family of α -Nacetylgalactosaminide α -2,6-sialyltransferases (ST6GalNAc). ST6GalNAc4 is strictly active on sT antigen and responsible for disialylated T antigen expression (Harduin-Lepers, A., Stokes, D.C., et al. 2000) .
Despite the abundance of N-and O-glycans and their important biological functions, research on these glycans was hampered for the lack of high affinity (Ambrosi, M., Cameron, N.R., et al. 2005 ) and specific binding reagents (Geisler, C. and Jarvis, D.L. 2011, Sterner, E., Flanagan, N., et al. 2016) . The emerge of click chemistry (Kolb, H.C., Finn, M.G., et al. 2001 ) and metabolic glycan labeling using clickable carbohydrate (Codelli, J.A., Baskin, J.M., et al. 2008 , Hsu, T.L., Hanson, S.R., et al. 2007 , Kizuka, Y., Funayama, S., et al. 2016 made generic glycan imaging possible. Subsequently, enzymatic glycan labeling using clickable sugars made some specific glycan imaging feasible (Chaubard, J.L., Krishnamurthy, C., et al. 2012 , Mbua, N.E., Li, X., et al. 2013 , Wu, Z.L., Person, A.D., et al. 2018 ) (Method I in Fig. 1D ). Recently, probing or labeling N-glycans and sT antigen via direct incorporation of biotinylated sialic acids have been reported, respectively, via ST6Gal1 (Capicciotti, C.J., Zong, C., et al. 2017 ) and ST6GalNAc4 (Wen, L., Liu, D., et al. 2018 ) (Method II in Fig. 1D ). Here, we describe the specific imaging of these glycans on HeLa cells via Direct Fluorescent Glycan Labeling (DFGL) where fluorophoreconjugated sialic acids are directly enzymatically incorporated to the target glycans (Method III in Fig. 1D ).
HeLa cells are derived from human cervical cancer cells (Scherer, W.F., Syverton, J.T., et al. 1953 ) and are genetically stable (Adey, A., Burton, J.N., et al. 2013) . HeLa cells are also known to express CA125, a glycoprotein cancer marker that carries T/sT antigens (Seelenmeyer, C., Wegehingel, S., et al. 2003) . By comparing the images of N-glycan and T/sT antigens, we found that these glycans on HeLa cells have different localization, and, more interestingly, the expression of sT antigen on HeLa cells displays random and sporadic patterns that are likely age and stress dependent. F  l  u  o  r  o  p  h  o  r  e  C  o  n  j  u  g  a  t  e  d  S  i  a  l  i  c  A  c  i  d  s  c  a  n  b  e  D  i  r  e  c  t  l  y  I  n  t  r  o  d  u  c  e  d  t  o  G  l  y  c  o  p  r  o  t  e  i  n  b  y  V  a  r  i  o  u  s  S  i  a  l  y  l  t  r  a  n  s  f  e  r  a  s  e  s Fluorophore conjugated CMP-sialic acids (CMP-SA) were synthesized by incubating equivalent CMP-azido-sialic acid (CMP-N 3 -SA) and an alkyne fluorophore via copper (I)-catalyzed azidealkyne cycloaddition (Rostovtsev, V.V., Green, L.G., et al. 2002) . Alexa Fluor® 555 conjugated CMP-sialic acid was first tested on fetal bovine fetuin using various sialyltransferases. The labeling reactions were separated on SDS-PAGE and directly imaged with a regular protein gel imager ( Fig. 2A ) and a fluorescent gel imager ( Fig.2B and 2C ). As results, Alexa Fluor® 555 conjugated sialic acid was directly introduced to asialofetuin strongly by ST3Gal1, ST3Gal2 and ST6Gal1, and, weakly by ST6GalNAc1 and ST6GalNAc2. In contrast, the fluorescent sialic acid was directly introduced to fetuin only by ST6GalNAc1, ST6GalNAc2 and ST6GalNAc4.
Therefore, ST3Gal1, ST3Gal2, ST6Gal1 showed strict specificity towards asialofetuin and ST6GalNAc4 showed strict specificity towards fetuin, which is consistent to the observation previously achieved with azido-sialic acid (Wu, Z.L., Huang, X., et al. 2016 D  i  f  f  e  r  e  n  t  i  a  l  D  i  s  p  l  a  y  o  f  N  -a  n  d  O  -g  l  y  c  a  n  s  o  n  H  e  L  a  C  e  l  l  s For their strict substrate specificities, ST3Gal1, ST6Gal1 and ST6GalNAc4 were then selected to image their substrate glycans on confluent HeLa cells grown in a 96-well plate using Alexa Fluor® 555 conjugated CMP-SA ( Fig. 3) . Some cells were pretreated with C. perfringens neuraminidase (Corfield, A.P., Higa, H., et al. 1983 ) briefly to remove the existing α 2-3 and α 2-6 linked sialic acids before imaging. As results, ST3Gal1 and ST6Gal1 produced strong staining only after the neuraminidase treatment, suggesting that Core-1 O-glycans (or T antigen) and Nglycans were largely sialylated on the HeLa cells. In contrast, ST6GalNAc4 only produced strong staining prior to neuraminidase treatment, indicating the presence of sT antigen on the HeLa cells. Interestingly, while ST3Gal1 and ST6GalNAc4 staining was distributed throughout the cells ( Fig. 3B and 3C ), ST6Gal1 staining was more peripherally localized ( Fig. 3. F) . For comparison, some cells were also imaged by OGT ( Fig. 3. H) , an enzyme that strictly recognizes To confirm that O-and N-glycans have different localization, HeLa cells at different confluence were double imaged by ST3Gal1 and ST6Gal1 (Fig. 4) , in which Alexa Fluor® 555 conjugated sialic acid was first introduced by ST3Gal1 followed by the introduction of Alexa Fluor® 488 conjugated sialic acid by ST6Gal1. Again, it was observed that N-glycans revealed by ST6Gal1
were preferentially expressed at the cell edges and Core-1 O-glycans were more evenly distributed on cells (also see in Supplemental Fig. 2 ).
To better understand the expression of N-glycans, HeLa cells of increasing confluence were imaged by ST6Gal1 (Supplemental Fig. 3 ). At about 50% culture confluence, N-glycans already displayed preferential distribution at peripheral positions. It seemed that the N-glycans tend to accumulate at the cell edges during growth possibly for cell attachment and migration. This tendency continued until 100% confluence was reached, in which glycocalyx were merged and condensed to ridges between cells ( Fig. 4C To confirm and better understand the mosaic expression of sT antigen observed in Fig.3C , confluent HeLa cells that were imaged by ST6GalNAc4 were further imaged by OGT to reveal all cells ( Fig. 5 ). Again, sT antigen expression varied significantly from cell to cell, with some cells being strongly positive and some cells being almost completely negative. Occasionally, a positive cell was found to be surrounded by negative cells (circled in Fig. 5B ), suggesting that the positive cell be derived from the negative cells, as it is unlikely for a single positive cell being trapped among negative cells during cell division and migration. Mosaic expression of T/sT antigen was also observed on HeLa cells imaged by ST3Gal1 (Supplemental Fig. 4 ).
HeLa cells are cancerous cells. The expression of sT carbohydrate cancer antigen on HeLa cells is not surprising (Seelenmeyer, C., Wegehingel, S., et al. 2003) . However, the mosaic expression of sT antigen is intriguing. Two hypotheses were postulated to explain this phenomenon. The first is that positive cells were derived from negative cells, which is suggested by Fig. 5 . The second is that the initial HeLa cell population were heterogeneous and contained positive subpopulation. To test the second hypothesis, HeLa cells from the above experiments were subject to further clonal selection, by which single cells were selected and cultivated under the same conditions for 11-14 days to form individual colonies. When imaged by ST6GalNAc4 at day 11, sT antigen positive cells were sporadically found throughout the colonies but more abundantly around the centers of these colonies ( Fig. 6 ). More sT antigen positive cells were found around the centers of these colonies at day 14 (Supplemental Fig. 5 ). Since cells around the centers of the colonies are older and more crowded (more stress) than cells at peripheral positions, the above observations together argue that sT antigen positive cells were derived from sT antigen negative cells and sT antigen expression is age/stress dependent. As a technique, DFGL has several advantages over previous methods for glycan labeling/imaging. First, the method is more convenient and time-saving by involving only a single step of enzymatic reaction prior to cell imaging and allowing direct imaging of an SDS gel without the time-consuming membrane transfer step in Western blotting. Second, this method has eliminated the side effect of oxidative cleavage of target proteins and is more suitable for live cell imaging by avoiding the usage of copper ion of traditional click chemistry reaction. Third, this method allows double or multiple imaging of different glycans simultaneously without cross-staining of these glycans by avoiding the common intermediate step of biotin-streptavidin reaction. Fourth, since fluorophore is introduced only by enzymatic reaction, the labeling/detection of a certain glycan is more specific and has lower background. In summary, DFGL is a convenient tool for specific glycan detection, labeling and imaging. It is also foreseeable that this technique can be applied to detect other types of glycans using different glycosyltransferases and fluorophore-conjugated sugars as donor substrates.
The fact that specific glycan structures can be reproducibly generated by normal cells without templates suggests that the Golgi apparatus has an extremely well-organized structure with the synthetic glycosyltransferases localized in precise order. It is hypothesized that this ordered structure in HeLa cells or pre-cancerous cells is rather fragile and easy to be disrupted under the effects of age and/or stress, leading to premature synthesis of abnormal shortened glycan epitopes.
Cancers were considered as genetic diseases (Alexandrov, L.B., Nik-Zainal, S., et al. 2013) .
However, recent work suggests that mutations of oncogenes arise in normal tissues may not necessarily lead to cancer (Martincorena, I., Fowler, J.C., et al. 2018) . Direct causes of cancerous phenotype may need additional factors, such as environmental triggers (Chanock, S.J. 2018) .
Conversely, a cancerous phenotype may not be a direct outcome of genetic mutations.
Accordingly, our results on sT antigen imaging strongly argue that its expression is not due to immediate genetic mutation but caused by disrupted posttranslational machinery. Recently, glycan cancer antigens have been targeted for cancer immunotherapy (Posey, A.D., Jr., Schwab, R.D., et al. 2016 , Steentoft, C., Migliorini, D., et al. 2018 
For a typical cell imaging on a 96-well plate, the medium in each well was removed and replaced with a labeling mixture containing 0.2 nmol of a fluorophore-conjugated CMP-SA, 0.5 µg of a sialyltransferase, 30 µL labeling buffer (25 mM Tris pH 7.5, 150 mM NaCl, 10 mM Mn 2+ ) and 20 µL of the original medium, and the cells were then incubated at 37 o C for 20 minutes. For cell imaging using ST3Gal1 or ST6Gal1, cells in each well were pretreated with 1 µg of C.p
Neuraminidase directly in the medium at 37 o C for 10 minutes prior to the labeling. After the labeling, the cells were washed three times quickly each with 150 µL 25 mM Tris pH 7.5, 150
mM NaCl. For double imaging with another fluorophore, the cells were incubated with a second labeling mixture at 37 o C for 20 minutes and then washed thoroughly, followed by fixation in 4% paraformaldehyde for 10 minutes at room temperature. The fixed cells were then stored in the buffer of 25 mM Tris pH 7.5, 150 mM NaCl for imaging. We want to acknowledge numerous colleagues who have made contributions to this manuscript through product development, quality control and assurance, and product support. A and B) and fully confluence (C and D) conditions were briefly treated with C. perfringens neuraminidase to remove preexisting sialic acids and then imaged for Core-1 O-glycans by ST3Gal1 using Alexa Fluor® 555 conjugated CMP-SA (red) and N-glycans by ST6Gal1 using Alexa Fluor® 488 conjugated CMP-SA (green). A and B are for the exact same viewing area. C and D are for the exact same viewing area. Cell nuclei were revealed with DAPI staining in blue in B and D. N-glycans are expressed preferentially at peripheral positions, especially on protrusions of the cells, compared to Core-1 O-Glycans that are more centralized and evenly distributed on cells. 
